Markus Bredemeier

12PUBLICATIONS
19CO-AUTHORS
Medical bacteriologyMedical mycologyPainFood properties (incl. characteristics and health benefits)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 22, 2023
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.

Markus Bredemeier, Ângela L Duarte, Marcelo M Pinheiro

|Feb 17, 2023
A destructive nasal skin lesion caused by fungal infection in a systemic lupus erythematosus patient.

Mônica Ribeiro de Campos, Felipe Cargnelutti Possamai Della, Camila Lucía Veroneze Solórzano

|Dec 15, 2021
Personalized multitarget biologic injection in the spine: prospective case series of multitarget platelet-rich plasma for low back pain.

Edilson S Machado, Mary A Ambach, José Mp Caldas

|Oct 06, 2021
Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease: comment on the article by Khanna et al.

Markus Bredemeier

|Jun 09, 2021
Clinical and Methodologic Considerations With Regard to a Trial of Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Comment on the Reanalysis by Maher et al.

Markus Bredemeier

|May 02, 2021
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).

Markus Bredemeier, Roberto Ranza, Adriana M Kakehasi

Pageof 2

Frequent Collaborators

2 joint publications

Edilson Silva Machado

2 joint publications

José Mp Caldas

1 joint publications

Renata Leite

1 joint publications

Cintia Cichowski Dos Santos